DRMA
Price
$1.04
Change
-$0.06 (-5.45%)
Updated
Dec 18, 04:59 PM (EDT)
KRRO
Price
$45.21
Change
-$4.55 (-9.14%)
Updated
Dec 18, 04:19 PM (EDT)
Ad is loading...

DRMA vs KRRO

Header iconDRMA vs KRRO Comparison
Open Charts DRMA vs KRROBanner chart's image
Dermata Therapeutics
Price$1.04
Change-$0.06 (-5.45%)
Volume$500
CapitalizationN/A
Korro Bio
Price$45.21
Change-$4.55 (-9.14%)
Volume$100
CapitalizationN/A
DRMA vs KRRO Comparison Chart
Loading...
DRMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRMA vs. KRRO commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRMA is a Hold and KRRO is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (DRMA: $1.10 vs. KRRO: $49.76)
Brand notoriety: DRMA and KRRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DRMA: 31% vs. KRRO: 74%
Market capitalization -- DRMA: $2.24M vs. KRRO: $466.16M
DRMA [@Biotechnology] is valued at $2.24M. KRRO’s [@Biotechnology] market capitalization is $466.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRMA’s FA Score shows that 1 FA rating(s) are green whileKRRO’s FA Score has 0 green FA rating(s).

  • DRMA’s FA Score: 1 green, 4 red.
  • KRRO’s FA Score: 0 green, 5 red.
According to our system of comparison, KRRO is a better buy in the long-term than DRMA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRMA’s TA Score shows that 3 TA indicator(s) are bullish while KRRO’s TA Score has 7 bullish TA indicator(s).

  • DRMA’s TA Score: 3 bullish, 6 bearish.
  • KRRO’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, KRRO is a better buy in the short-term than DRMA.

Price Growth

DRMA (@Biotechnology) experienced а -19.71% price change this week, while KRRO (@Biotechnology) price change was +6.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

DRMA is expected to report earnings on May 11, 2023.

KRRO is expected to report earnings on Mar 27, 2024.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRRO($466M) has a higher market cap than DRMA($2.25M). KRRO YTD gains are higher at: 3.818 vs. DRMA (-87.978). DRMA has higher annual earnings (EBITDA): -11.53M vs. KRRO (-92.47M). KRRO has more cash in the bank: 137M vs. DRMA (6.14M). DRMA has less debt than KRRO: DRMA (175K) vs KRRO (41.8M). DRMA (0) and KRRO (0) have equivalent revenues.
DRMAKRRODRMA / KRRO
Capitalization2.25M466M0%
EBITDA-11.53M-92.47M12%
Gain YTD-87.9783.818-2,304%
P/E RatioN/AN/A-
Revenue00-
Total Cash6.14M137M4%
Total Debt175K41.8M0%
TECHNICAL ANALYSIS
Technical Analysis
DRMAKRRO
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 17 days ago
78%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 15 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
DRMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYHAX35.250.02
+0.06%
Rydex Health Care H
MFVSX17.20N/A
N/A
MassMutual Equity Opports R5
TEMLX8.03N/A
N/A
Nuveen Emerging Markets Eq R6
TICRX22.48-0.13
-0.57%
Nuveen Large Cap Responsible Eq A
REAYX26.62-0.16
-0.60%
Russell Inv Equity Income Y

KRRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRRO has been loosely correlated with PRQR. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if KRRO jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRRO
1D Price
Change %
KRRO100%
+3.32%
PRQR - KRRO
52%
Loosely correlated
+19.03%
WVE - KRRO
40%
Loosely correlated
+7.43%
ATNF - KRRO
37%
Loosely correlated
N/A
CDIO - KRRO
35%
Loosely correlated
-24.11%
HOWL - KRRO
33%
Poorly correlated
-1.20%
More